Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Assets (2020 - 2025)

Historic Return on Assets for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 0.15%.

  • Legend Biotech's Return on Assets fell 400.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.0% for FY2024, which is 3300.0% up from last year.
  • As of Q3 2025, Legend Biotech's Return on Assets stood at 0.15%, which was down 400.0% from 0.2% recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Return on Assets peaked at 0.0% during Q2 2021, and registered a low of 0.64% during Q4 2021.
  • Its 5-year average for Return on Assets is 0.22%, with a median of 0.17% in 2024.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -6400bps in 2021, then soared by 2600bps in 2024.
  • Legend Biotech's Return on Assets (Quarter) stood at 0.64% in 2021, then rose by 6bps to 0.6% in 2022, then soared by 66bps to 0.2% in 2023, then soared by 44bps to 0.11% in 2024, then tumbled by -34bps to 0.15% in 2025.
  • Its Return on Assets was 0.15% in Q3 2025, compared to 0.2% in Q2 2025 and 0.14% in Q1 2025.